COMPANY

Avanti Polar Lipids

avantiresearch.com ↗ · Southeast

FDA-cleared device company Past trials only

Keywords: research tools Cystic Fibrosis Pancreatic Insufficiency

Profile checked Oct 10, 2026

1Trials (company is sponsor)8NIH grants

Timeline

2007-01 Trial start Phase 2: Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT00406536	Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI	Phase 2	Completed	2007-01	2012-06 (actual)

NIH awards 8

Annual award amounts. Total $7.0M.

May 1, 2009 NIH award 1R41GM083393-01A2 FY2009: $241,675 awarded for that fiscal year; activity R41 (STTR); PI BURGESS, STEPHEN WAYNE; recipient as written: AVANTI POLAR LIPIDS, INC., ALABASTER, AL. Novel Reagents to Bypass Limi source ↗
Aug 11, 2008 NIH award 5R44DK060302-04 FY2008: $1,412,666 awarded for that fiscal year; activity R44 (SBIR); PI SHAW, WALTER A; recipient as written: AVANTI POLAR LIPIDS, INC., ALABASTER, AL. Organized Lipid Matrix: Fatty Acids a source ↗
Aug 15, 2007 NIH award 5R44DK060302-03 FY2007: $2,682,829 awarded for that fiscal year; activity R44 (SBIR); PI SHAW, WALTER A; recipient as written: AVANTI POLAR LIPIDS, INC., ALABASTER, AL. Organized Lipid Matrix: Fatty Acids a source ↗
Jun 26, 2006 NIH award 2R44DK060302-02A1 FY2006: $2,101,037 awarded for that fiscal year; activity R44 (SBIR); PI SHAW, WALTER A; recipient as written: AVANTI POLAR LIPIDS, INC., ALABASTER, AL. Organized Lipid Matrix: Fatty Acids source ↗
Jul 4, 2005 NIH award 1R41GM074429-01 FY2005: $100,000 awarded for that fiscal year; activity R41 (STTR); PI MACDONALD, ROBERT C; recipient as written: AVANTI POLAR LIPIDS, INC., ALABASTER, AL. Optimal Hydrophobicity of Lipoid G source ↗
Jul 11, 2003 NIH award 1R41CA102842-01 FY2003: $249,947 awarded for that fiscal year; activity R41 (STTR); PI MAURER, BARRY J; recipient as written: AVANTI POLAR LIPIDS, INC., ALABASTER, AL. PPMP as a Ceramide Catabolism Inhibito source ↗
Sep 17, 2001 NIH award 1R43DK060302-01 FY2001: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI SHAW, WALTER A; recipient as written: AVANTI POLAR LIPIDS, INC., ALABASTER, AL. Organized Lipid Matrix: Structural Inte source ↗
Sep 29, 1997 NIH award 1R41HL059003-01 FY1997: $99,462 awarded for that fiscal year; activity R41 (STTR); PI MATALON, SADIS; recipient as written: AVANTI POLAR LIPIDS, INC., ALABASTER, AL. AUGMENTATION OF GENE TRANSFER BY SURFACT source ↗